本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Taro Pharmaceutical Industries L

42.97
0.0000
成交量:- -
成交額:- -
市值:16.15億
市盈率:29.98
高:42.97
開:42.97
低:42.97
收:42.97
52周最高:42.97
52周最低:42.97
股本:3,758.46萬
流通股本:808.59萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):1.43
每股收益(LYR):1.43
淨資產收益率:3.06%
總資產收益率:0.21%
市淨率:0.90
市盈率(LYR):29.98

資料載入中...

2020/06/19

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/05/15

SEC問詢函

CORRESP [Cover] - Correspondence
2020/04/10

SEC問詢函

CORRESP [Cover] - Correspondence
2020/04/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/20

SEC問詢函

CORRESP [Cover] - Correspondence
2020/02/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/30

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/03

SEC問詢函

[Cover]Correspondence
2019/11/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/21

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]